FDA reaches "tipping point" after high-level departures Biotech and pharmaceutical companies rely on the FDA for guidance as they spend huge sums developing treatments. Axios · Dec 4, 2025
FDA drug chief signals possible exit as agency turmoil deepens Richard Pazdur’s potential retirement weeks into the role adds to upheaval at the FDA amid political pressure The Guardian - US · Dec 3, 2025
Turmoil and tensions at FDA after dramatic exit of top drug regulator Scramble to find replacement for George Tidmarsh shines light on dysfunction at US regulatory agency The Guardian - US · Nov 15, 2025
FDA Names Veteran Oncologist Richard Pazdur To Lead Drug Center After Ethics Scandal Ousts George Tidmarsh The U.S. Food and Drug Administration (FDA) has appointed Dr. Richard Pazdur as the new head of its drug center, succeeding Dr. George Tidmarsh, who was removed following an ethics complaint just months after his appointment. Benzinga · Nov 12, 2025